Literature DB >> 5322596

Incidence of candida in hospital in-patients and the effects of antibiotic therapy.

B J Smits, A P Prior, P G Arblaster.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1966        PMID: 5322596      PMCID: PMC1843387          DOI: 10.1136/bmj.1.5481.208

Source DB:  PubMed          Journal:  Br Med J        ISSN: 0007-1447


× No keyword cloud information.
  17 in total

1.  Identification of Canda albicans in primary culture.

Authors:  C O DAWSON
Journal:  Sabouraudia       Date:  1962-02

2.  Side-effects of tetracycline alone and of tetracycline with nystatin.

Authors:  R LARKIN
Journal:  Lancet       Date:  1959-06-13       Impact factor: 79.321

3.  Paronychia or perionychia: aetiological aspects.

Authors:  C H WHITTLE; J L MOFFATT; R A DAVIS
Journal:  Br J Dermatol       Date:  1959-01       Impact factor: 9.302

4.  A clinical comparison of the side effects of tetracycline-nystatin and tetracycline.

Authors:  D YOUNGER; L D EPIFANO; F DIPILLO; I HOFFMAN; E THALER; M YARVIS
Journal:  Antibiotic Med Clin Ther (New York)       Date:  1959-04

5.  Chronic paronychia. A mycological and bacteriological study.

Authors:  R H MARTEN
Journal:  Br J Dermatol       Date:  1959-12       Impact factor: 9.302

6.  Species of Candida most frequently isolated from man: methods and criteria for their identification.

Authors:  R W BENHAM
Journal:  J Chronic Dis       Date:  1957-04

7.  [Fungicides and mycotic therapy].

Authors:  E DROUHET
Journal:  Sem Hop       Date:  1957-02-28

8.  Monilial (Candida) endocarditis following treatment with antibiotics.

Authors:  H CAPLAN
Journal:  Lancet       Date:  1955-11-05       Impact factor: 79.321

9.  Monilia peritonitis.

Authors:  P C REYNELL; E A MARTIN; A W BEARD
Journal:  Br Med J       Date:  1953-04-25

10.  Tetracycline and tetracycline-nystatin in chronic urinary tract infections.

Authors:  C CHAMBERLAIN; H M BURROS; V BORROMEO
Journal:  Antibiotic Med Clin Ther (New York)       Date:  1958-08
View more
  15 in total

1.  Epidemiological investigations or oral Candida albicans.

Authors:  J A Schmitt
Journal:  Mycopathol Mycol Appl       Date:  1971-01-25

2.  Comparison of side-effects of tetracycline and tetracycline plus nystatin. Report to the Research Committee of the British Tuberculosis Association by the Clinical Trials Subcommittee.

Authors: 
Journal:  Br Med J       Date:  1968-11-16

3.  The incidence of fungi in the throat.

Authors:  P Martin; D Kanarek; S Zwi; A V Boyd; H J Koornhof
Journal:  Mycopathol Mycol Appl       Date:  1971-10-13

4.  Candida albicans colonisation, continence status and incontinence-associated dermatitis in the acute care setting: a pilot study.

Authors:  Jill L Campbell; Fiona M Coyer; Alison M Mudge; Ivan M Robertson; Sonya R Osborne
Journal:  Int Wound J       Date:  2016-08-01       Impact factor: 3.315

5.  Effects of minocycline and tetracycline on the vaginal yeast flora.

Authors:  J D Oriel; P M Waterworth
Journal:  J Clin Pathol       Date:  1975-05       Impact factor: 3.411

6.  Chemotherapy of experimental endogenous Candida albicans endophthalmitis.

Authors:  D B Jones
Journal:  Trans Am Ophthalmol Soc       Date:  1980

7.  Candida carriage in the alimentary tract of liver transplant candidates.

Authors:  S Kusne; D Tobin; A W Pasculle; D H Van Thiel; M Ho; T E Starzl
Journal:  Transplantation       Date:  1994-02       Impact factor: 4.939

8.  Dysphonia caused by inhaled steroids: recognition of a characteristic laryngeal abnormality.

Authors:  A J Williams; M S Baghat; D E Stableforth; R M Cayton; P M Shenoi; C Skinner
Journal:  Thorax       Date:  1983-11       Impact factor: 9.139

9.  Candida in the faeces of children receiving oral tetracycline and phenoxymethyl penicillin.

Authors:  R J Holt; R L Newman
Journal:  J Clin Pathol       Date:  1967-01       Impact factor: 3.411

Review 10.  Invasive oesophageal candidiasis: current and developing treatment options.

Authors:  Jose A Vazquez
Journal:  Drugs       Date:  2003       Impact factor: 9.546

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.